186 related articles for article (PubMed ID: 34240110)
1. Prevalence of nodal involvement in rectal cancer after chemoradiotherapy.
Haak HE; Beets GL; Peeters K; Nelemans PJ; Valentini V; Rödel C; Kuo L; Calvo FA; Garcia-Aguilar J; Glynne-Jones R; Pucciarelli S; Suarez J; Theodoropoulos G; Biondo S; Lambregts DMJ; Beets-Tan RGH; Maas M
Br J Surg; 2021 Oct; 108(10):1251-1258. PubMed ID: 34240110
[TBL] [Abstract][Full Text] [Related]
2. Prognostic impact of residual lateral lymph node metastasis after neoadjuvant (chemo)radiotherapy in patients with advanced low rectal cancer.
Akiyoshi T; Toda S; Tominaga T; Oba K; Tomizawa K; Hanaoka Y; Nagasaki T; Konishi T; Matoba S; Fukunaga Y; Ueno M; Kuroyanagi H
BJS Open; 2019 Dec; 3(6):822-829. PubMed ID: 31832589
[TBL] [Abstract][Full Text] [Related]
3. Comparative analysis of lymph node metastases in patients with ypT0-2 rectal cancers after neoadjuvant chemoradiotherapy.
Park IJ; You YN; Skibber JM; Rodriguez-Bigas MA; Feig B; Nguyen S; Hu CY; Chang GJ
Dis Colon Rectum; 2013 Feb; 56(2):135-41. PubMed ID: 23303140
[TBL] [Abstract][Full Text] [Related]
4. Poorer Oncologic Outcome of Good Responders to PCRT With Remnant Lymph Nodes Defies the Oncologic Paradox in Patients With Rectal Cancer.
Cho E; Park IJ; Hong SM; Lee JL; Kim CW; Yoon YS; Lim SB; Yu CS; Kim JC
Clin Colorectal Cancer; 2019 Jun; 18(2):e171-e178. PubMed ID: 31027968
[TBL] [Abstract][Full Text] [Related]
5. Stage-Dependent Frequency of Lymph Node Metastases in Patients With Rectal Carcinoma After Preoperative Chemoradiation: Results from the CAO/ARO/AIO-94 Trial and From a Comparative Prospective Evaluation With Extensive Pathological Workup.
Sprenger T; Rothe H; Conradi LC; Beissbarth T; Kauffels A; Kitz J; Homayounfar K; Wolff H; Ströbel P; Ghadimi M; Wittekind C; Sauer R; Rödel C; Liersch T
Dis Colon Rectum; 2016 May; 59(5):377-85. PubMed ID: 27050599
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of metastatic lymph node regression grade after neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer.
Tominaga T; Akiyoshi T; Yamamoto N; Oba K; Nagasaki T; Yamaguchi T; Konishi T; Fukunaga Y; Ueno M
Surgery; 2019 Dec; 166(6):1061-1067. PubMed ID: 31345564
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of pathological node status after neoadjuvant radiotherapy for rectal cancer.
Duchalais E; Glyn Mullaney T; Spears GM; Kelley SR; Mathis K; Harmsen WS; Larson DW
Br J Surg; 2018 Oct; 105(11):1501-1509. PubMed ID: 29663352
[TBL] [Abstract][Full Text] [Related]
8. Prognostic subdivision of ypT3 rectal tumours according to extension beyond the muscularis propria.
Merkel S; Weber K; Schellerer V; Göhl J; Fietkau R; Agaimy A; Hohenberger W; Hermanek P
Br J Surg; 2014 Apr; 101(5):566-72. PubMed ID: 24477831
[TBL] [Abstract][Full Text] [Related]
9. Lymph node regression after neoadjuvant chemoradiotherapy in rectal cancer.
Ozturk SK; Martinez CG; Mens D; Verhoef C; Tosetto M; Sheahan K; de Wilt JHW; Hospers GAP; van de Velde CJH; Marijnen CAM; van der Post RS; Nagtegaal ID
Histopathology; 2024 May; 84(6):935-946. PubMed ID: 38192084
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Implication of Negative Lymph Node Count in ypN+ Rectal Cancer after Neoadjuvant Chemoradiotherapy and Construction of a Prediction Nomogram.
Sun Y; Zhang Y; Huang Z; Chi P
J Gastrointest Surg; 2019 May; 23(5):1006-1014. PubMed ID: 30187336
[TBL] [Abstract][Full Text] [Related]
11. Can clinicopathological parameters predict for lymph node metastases in ypT0-2 rectal carcinoma? Results of the CAO/ARO/AIO-94 and CAO/ARO/AIO-04 phase 3 trials.
von den Grün JM; Hartmann A; Fietkau R; Ghadimi M; Liersch T; Hohenberger W; Weitz J; Sauer R; Wittekind C; Ströbel P; Rödel C; Fokas E;
Radiother Oncol; 2018 Sep; 128(3):557-563. PubMed ID: 29929861
[TBL] [Abstract][Full Text] [Related]
12. Nonmetastatic ypt0 rectal cancer after neoadjuvant treatment and total mesorectal excision: Lessons from a retrospective multicentric cohort of 383 patients.
Collard MK; Rullier E; Panis Y; Manceau G; Benoist S; Tuech JJ; Alves A; Laforest A; Mege D; Cazelles A; Beyer-Berjot L; Christou N; Cotte E; Lakkis Z; O'Connell L; Parc Y; Piessen G; Lefevre JH;
Surgery; 2022 May; 171(5):1193-1199. PubMed ID: 35078629
[TBL] [Abstract][Full Text] [Related]
13. Prognostic Impact of Extranodal Extension in Rectal Cancer Patients Undergoing Radical Resection After Preoperative Chemoradiotherapy.
Kim YI; Cho H; Kim CW; Park Y; Kim J; Ro JS; Lee JL; Yoon YS; Park IJ; Lim SB; Yu CS; Kim JC
Clin Colorectal Cancer; 2021 Mar; 20(1):e35-e42. PubMed ID: 33191166
[TBL] [Abstract][Full Text] [Related]
14. YpN0 rectal cancer patients with sterilized lymph nodes after neoadjuvant chemoradiotherapy are of greater risk of recurrence.
Manceau G; Margot N; Augustin J; Bardier A; Simon JM; Bachet JB; Spano JP; Maingon P; Vaillant JC; Karoui M
Dig Liver Dis; 2020 Feb; 52(2):214-220. PubMed ID: 31427089
[TBL] [Abstract][Full Text] [Related]
15. Prognostic Value of Lymph Node Ratio in Locally Advanced Rectal Cancer Patients After Preoperative Chemoradiotherapy Followed by Total Mesorectal Excision.
Zuo ZG; Zhang XF; Wang H; Liu QZ; Ye XZ; Xu C; Wu XB; Cai JH; Zhou ZH; Li JL; Song HY; Luo ZQ; Li P; Ni SC; Jiang L
Medicine (Baltimore); 2016 Mar; 95(9):e2988. PubMed ID: 26945418
[TBL] [Abstract][Full Text] [Related]
16. Magnetic resonance tumour regression grade and pathological correlates in patients with rectal cancer.
Jang JK; Lee JL; Park SH; Park HJ; Park IJ; Kim JH; Choi SH; Kim J; Yu CS; Kim JC
Br J Surg; 2018 Nov; 105(12):1671-1679. PubMed ID: 29893988
[TBL] [Abstract][Full Text] [Related]
17. Lymph node metastases in rectal cancer after preoperative radiochemotherapy: impact of intramesorectal distribution and residual micrometastatic involvement.
Sprenger T; Rothe H; Becker H; Beissbarth T; Homayounfar K; Gauss K; Kitz J; Wolff H; Scheel AH; Ghadimi M; Rödel C; Conradi LC; Liersch T
Am J Surg Pathol; 2013 Aug; 37(8):1283-9. PubMed ID: 23851331
[TBL] [Abstract][Full Text] [Related]
18. [Lymph node metastases in ypT1/2 rectal cancer after neoadjuvant chemoradiotherapy : The Achilles heel of organ-preserving operative procedures?].
Sprenger T; Rothe H; Beissbarth T; Conradi LC; Kauffels A; Homayounfar K; Behnes CL; Rödel C; Liersch T; Ghadimi M
Chirurg; 2016 Jul; 87(7):593-601. PubMed ID: 27106241
[TBL] [Abstract][Full Text] [Related]
19. Neoadjuvant therapy for rectal cancer: histologic response of the primary tumor predicts nodal status.
Read TE; Andujar JE; Caushaj PF; Johnston DR; Dietz DW; Myerson RJ; Fleshman JW; Birnbaum EH; Mutch MG; Kodner IJ
Dis Colon Rectum; 2004 Jun; 47(6):825-31. PubMed ID: 15108025
[TBL] [Abstract][Full Text] [Related]
20. Rectal cancer patients after neoadjuvant radiotherapy (30Gy/10f) with negative lymph node may not benefit from postoperative adjuvant chemotherapy: a retrospective study.
Chen P; Yao Y; Gu J
Int J Colorectal Dis; 2015 Dec; 30(12):1695-704. PubMed ID: 26278877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
